Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,425 | 64,208 | 95,534 | 115,174 | 205 |
| Marketable Securities | 29,154 | N/A | N/A | N/A | N/A |
| Receivables | 35,379 | 29,369 | 25,792 | 21,244 | N/A |
| Inventories | 10,018 | 8,580 | 7,770 | 6,438 | N/A |
| TOTAL | $143,631 | $112,205 | $139,840 | $154,056 | $287 |
| Non-Current Assets | |||||
| PPE Net | 7,006 | 6,014 | 4,909 | 4,192 | N/A |
| Investments And Advances | 58,215 | 0 | 0 | 0 | 0 |
| Intangibles | 49,681 | 53,859 | 44,198 | 44,871 | 0 |
| Other Non-Current Assets | 25,269 | 17,662 | 17,565 | 320 | 230,013 |
| TOTAL | $140,171 | $77,535 | $66,672 | $49,383 | $230,013 |
| Total Assets | $283,802 | $189,740 | $206,512 | $203,439 | $230,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | N/A | N/A | 183 | N/A |
| Accounts payable and accrued liabilities | 11,155 | 13,900 | 12,596 | 15,559 | 961 |
| Accrued Expenses | 16,147 | 17,610 | 14,516 | 13,924 | 2,643 |
| TOTAL | $32,852 | $36,128 | $31,521 | $29,798 | $3,634 |
| Non-Current Liabilities | |||||
| Long Term Debt | 79,069 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 43,393 | 29,127 | 42,442 | 69,111 | 245,268 |
| TOTAL | $123,016 | $29,629 | $42,993 | $69,482 | $251,568 |
| Total Liabilities | $155,868 | $65,757 | $74,514 | $99,280 | $255,202 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,342 | 72,140 | 73,276 | 73,249 | 28,750 |
| Common Shares | 7 | 7 | 7 | 7 | 1 |
| Retained earnings | -52,075 | -49,401 | -43,948 | -63,234 | -24,903 |
| TOTAL | $127,934 | $123,983 | $131,998 | $104,159 | $-24,903 |
| Total Liabilities And Equity | $283,802 | $189,740 | $206,512 | $203,439 | $230,300 |